Taro Pharmaceutical Industries (TARO) Reports Improved Q2 EPS of $1.46

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) reported Q2 EPS of $1.46, versus $1.32 reported last year. Revenue for the quarter came in at $160.97 million, versus $138.25 million reported last year.

For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance